Phase II study of a PARP inhibitor in metastatic breast cancer with somaticBRCA1/2mutations identified by cell-free DNA: Genotyping based clinical trialNeelima Vidula,Erica Blouch, Erin Basile,Nathan Royce Ruffle-Deignan,Nora Horick,Senthil Damodaran, Alvaro Moreno Aspitia, Manali Bhave,Ami Shah,Minetta C. Liu,Joseph Sparano,Harry Ostrer,Hope Rugo,Leif W. Ellisen,Aditya BardiaCANCER RESEARCH（2022）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
